SEP-363856 for schizophrenia
This study was terminated in China, in Japan, in the Philippines, .... It is testing SEP-363856 for schizophrenia.
Multiple locations, including Beijing
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study was terminated in China, in Japan, in the Philippines, .... It is testing SEP-363856 for schizophrenia.
Multiple locations, including BeijingThis study has public registry information. It focuses on schizophrenia and currently lists study information in Japan.
Multiple locations, including Konan-shiThis study is completed in the United States, in Bulgaria, in Colombia, .... It is testing investigational Drug for schizophrenia.
Multiple locations, including Little RockThis study is active but not recruiting. It focuses on depression and currently lists study information in the United States.
In San FranciscoThis study is completed. It focuses on PTSD and currently lists study information in the United States.
In AlbuquerqueThis study was terminated in Brazil. It focuses on depression.
In BrazilThis study is active but not recruiting. It focuses on schizophrenia and currently lists study information in Norway.
In BergenThis study is completed. It focuses on anxiety and currently lists study information in Indonesia.
In PalangkarayaThis study is completed. It focuses on PTSD and currently lists study information in the United States.
In SeattleThis study is completed. It focuses on anxiety and currently lists study information in Italy.
In TroinaThis study is completed. It focuses on PTSD and currently lists study information in the United States.
In CincinnatiThis study is completed. It focuses on PTSD and currently lists study information in the United States.
In CincinnatiHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.